Multiple Myeloma Research Foundation (MMRF) Announces New Publication on CoMMpass℠ Study in Nature Genetics Defining Distinct Subtypes of Multiple Myeloma and High-Risk Genetic Markers
August 19, 2024 05:05 ET
|
Multiple Myeloma Research Foundation
This MMRF-led collaborative initiative is the largest single sequencing study of multiple myeloma patients to dateCoMMpass findings provide an unprecedented, clearer definition of patients at highest...
International Myeloma Foundation Medical Student Scholars for Health Equity in Myeloma Present Posters at the 2024 NMA Annual Convention & Scientific Assembly
August 15, 2024 08:45 ET
|
International Myeloma Foundation
NEW YORK, Aug. 15, 2024 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF), in partnership with the National Medical Association (NMA), the W. Montague Cobb Institute, and the Student...
Bionano Announces Publication of First Multi-Site Study to Analyze the Utility of OGM in Multiple Myeloma
July 23, 2024 08:00 ET
|
Bionano Genomics
SAN DIEGO, July 23, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced the publication of the first multi-site study in multiple myeloma (MM) comparing optical genome...
The International Myeloma Foundation Mourns the Passing of IMF Board Member and Support Group Leader Jack Aiello
July 16, 2024 08:45 ET
|
International Myeloma Foundation
STUDIO CITY, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Today, the International Myeloma Foundation (IMF) announced with great sadness, the passing of one of the IMF’s Board Members, Myeloma Support...
The International Myeloma Foundation Thanks Dr. Brian G.M. Durie for 35 Years of Remarkable Leadership
July 03, 2024 08:45 ET
|
International Myeloma Foundation
The IMF has established a new Scientific Advisory Board. The Scientific Advisory Board includes an esteemed group of global myeloma experts.
Starton Therapeutics Announces 100% Partial Response or Better in Multiple Myeloma Patients in Interim, Top-line Data from STAR-LLD Phase 1b Clinical Trial
June 21, 2024 08:05 ET
|
Starton Therapeutics
100% of patients enrolled achieved a partial response or betterMilder and less frequent drug-related adverse events were observed compared to those associated with Revlimid®No grade 3 or greater...
"I Have Insurance, Why Can't I Afford My Oral Anticancer Medications?" International Myeloma Foundation Highlights the Urgent Need for Cancer Drug Parity Act at Congressional Briefing
June 18, 2024 12:46 ET
|
International Myeloma Foundation
The International Myeloma Foundation-led CIACC hosted a Congressional Briefing addressing the issue of insurance coverage for oral anticancer medications.
Global Multiple Myeloma Markets, 2018-2034: Epidemiology, Pipeline Drugs, Challenges, Opportunities, Reimbursement Scenario, Unmet Needs, and More
June 12, 2024 11:37 ET
|
Research and Markets
Dublin, June 12, 2024 (GLOBE NEWSWIRE) -- The "Multiple Myeloma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034" report has been added to ...
International Myeloma Foundation (IMF) to Honor 2024 Kyle and Durie Achievement Awardees, Dr. Shaji Kumar and Dr. Francesca Gay
June 11, 2024 08:45 ET
|
International Myeloma Foundation
International Myeloma Foundation (IMF) to Honor 2024 Kyle and Durie Achievement Awardees, Dr. Shaji Kumar and Dr. Francesca Gay.
International Myeloma Foundation Holds 15th Annual Gala at the Edison Ballroom in New York City on April 18
April 25, 2024 08:45 ET
|
International Myeloma Foundation
On April 18, the International Myeloma Foundation held its 15th Annual Gala at the Edison Ballroom for the first time in New York, hosted by Ray Romano.